“Most men with early-stage prostate cancer will die with their disease, not from their disease,” Dr Murphy said. Partial gland ablation of MRI-invisible prostate cancer has been controversial. Partial ...

Effect of undetectable PSA following SRT for biochemical recurrence on BPFS, FFM, and OS. Short term pathologic outcomes and biochemical recurrence rates of single port transvesical retzius-sparing ...

Vascular-targeted photodynamic therapy continues to shows efficacy for partial gland ablation of intermediate-risk prostate cancer with minimal toxicity, according to long-term follow-up results from ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

It’s among the most common cancers affecting older men. But a diagnosis today isn’t always what it seems. By David Dodge An estimated one in eight men will be diagnosed with prostate cancer in their ...

Mr. Green, a 50-something businessman was asking a question I find myself answering on a surprisingly regular basis: “So, my ...